je.st
news
Seattle Genetics' pipeline investments lead to $27M Q4 loss, stock up slightly
2015-02-11 03:12:04| Biotech - Topix.net
Bothell-based biotech Seattle Genetics , which develops cancer treatments, posted a $27 million loss on revenue of $74 million in its fourth quarter earnings today. While the company's overall sales of $74 million in the fourth quarter increased from $67 million in fourth quarter 2013, its losses also increased to $27 million from $15.7 million during the same quarter a year ago.
Tags: up
stock
lead
loss
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||